Adicet Bio Gets Fast Track Designation For ADI-001 In Refractory Systemic Lupus Erythematosus
Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food ...
Healio3d
Menopausal hormone therapy may increase risks for lupus, systemic sclerosis
The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...
Healio6d
Survival better with lobectomy vs. wedge resection in early stage lung cancer
Among patients with stage IA non-small cell lung cancer, long-term survival was better with lobectomy or segmentectomy vs.
Fate Therapeutics' SWOT analysis: stock poised for catalysts amid clinical progress
Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...